Variables | Male | Female | ||||
---|---|---|---|---|---|---|
Total effect (95%CI) | Direct effect (95%CI) | Indirect effect (95%CI) | Total effect (95%CI) | Direct effect (95%CI) | Indirect effect (95%CI) | |
Obesity –- > BP | 0.24(0.21—0.27) | 0.24(0.21—0.27) | –– | 0.15(0.12—0.18) | 0.15(0.12—0.18) | –– |
Lipid profile–- > BP | 0.13(0.10—0.16) | 0.05(0.02—0.08) | 0.08(0.06—0.09) | 0.13( 0.10, 0.15) | 0.09(0.07, 0.12) | 0.04(0.02, 0.05) |
SES –- > BP | -0.09(-0.13, -0.06) | -0.13(-0.17,—0.09) | 0.04(0. 02, 0.05) | -0.14(-0.18, -0.06) | -0.17(-0.20, -0.13) | 0.03( 0.02, 0.04) |
Diabetes–- > BP | –- | –- | –- | 0.03(0.02, 0.05) | 0.03(0.02, 0.05) | –- |
MET –- > BP | -0.04(-0.07, -0.01) | –- | -0.04(-0.07, -0.01) | -0.04(-0.07, -0.02) | –– | -0.04(-0.07, -0.02) |
HTNDRUG –- > BP | -0.29 (-0.32, -0.25) | -0.29 (-0.32, -0.25) | –- | -0.33 (-0.36, -0.30) | -0.33 (-0.36, -0.30) | –- |
HTN family–- > BP | 0.02(0.02, 0.05) | 0.02(0.02, 0.05) | –– | 0.03(0.01, 0.06) | 0.03(0.01, 0.06) | –- |
MET –- > obesity | -0.11 (-0.15, -0.08) | -0.08 (-0.11, -0.05) | -0.03 (-0.04, -0.02) | -0.08 (-0.11, -0.05) | -0.07 (-0.10, -0.04) | -0.01 (-0.01, -0.03) |
MET–- > lipid profile | -0.11 (-0.13, -0.07) | -0.11 (-0.13, -0.07) | –- | -0.07 (-0.09, -0.04) | -0.07 (-0.09, -0.04) | –- |
MET–- > Diabetes | -0.06 (-0.09, -0.03) | -0.06 (-0.09 -0.03) | –- | -0.03(-0.09, -0.03) | -0.02 (-0.05, -0.03) | -0.01 (-0.01, -0.03) |
Lipidprofile–- > obesity | 0.32(0.30, 0.35) | 0.32(0.30, 0.35) | –- | 0.21(0.18, 0.24) | 0.21(0.18, 0.24) | –- |
SES–- > METs | -0.39 (-0.41, -0.36) | -0.39 (-0.41, -0.36) | –– | -0.23 (-0.26, -0.19) | -0.23 (-0.26, -0.19) | –- |
SES–- > Obesity | 0.13 (0.09, 0.16) | 0.08 (0.04, 0.12) | 0.05 (0.03, 0.06) | 0.10 (0.06, 0.13) | 0.08 (0.04, 0.12) | 0.02 (0.01, 0.02) |
SES–- > Lipid profile | 0.04 (0.03, 0.05) | ––- | 0.04 (0.03, 0.05) | 0.01 (0.01, 0.02) | ––- | 0.01 (0.01, 0.02) |
Lipid profile –- > Diabetes | –- | –- | –- | 0.04 (0.01,0.07) | 0.04 (0.01,0.07) | –- |